Here's what Gov. Katie Hobbs said when she delivered her third State of the State address at the Arizona Capitol on Monday.
Boosting revenue through increased advertising, sweeping job cuts, and the ability to pay for a blue verified badge are some of ... including Pfizer, GSK, and Novo Nordisk. On 14 November, Eli ...
Cluster of cops appear to be stationed in the area surrounding the hotel and metal barriers line the entrances of the venue, which are flanked by several private security guards checking badges of ...
GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...
Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has bee ...
Brand New Membership Level: Benzinga Trade Alerts GSK plc GSK expects strong momentum in the specialty business segment to continue with growth from existing assets. At the JPMorgan Healthcare ...
The company plans five new product approvals in 2025, including Blenrep for multiple myeloma and depemokimab for severe asthma. Specialty medicines accounted for more than 80% of GSK's growth in ...
Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...
GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency
If approved, the new presentation will offer a convenient administration option to healthcare professionals Globally, up to 1 in 3 adults will develop shingles in their lifetime 1,2,3,4 Over 25 ...
International drug giant GSK plc is moving its vaccine R&D and infectious disease teams to Cambridge from Maryland, and plans to expand its footprint here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results